logo

PETQ(Delisted)

PetIQ·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 0
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About PETQ

Petiq, Inc.

A leading pet medication and wellness company

--
02/29/2016
07/21/2017
NASDAQ Stock Exchange
1,933
12-31
Common stock
230 E. Riverside Drive, Eagle, Idaho 83616
--
PetIQ, Inc., was incorporated as a Delaware corporation on February 29, 2016. The company was formed to complete a public offering and related transactions to conduct the business of PetIQ LLC, an Idaho limited liability company. PetIQ is a fast-growing distributor and manufacturer of veterinary grade pet Rx drugs, OTC flea and tick preventives, and dog and cat health and wellness products. The company pioneered and is a major seller of retail channels for pet products, previously purchased primarily from veterinary clinics. The company is able to offer its customers a leading national brand of pet owner choice, economy and convenience products, as well as an alternative to its proprietary value brands. Consumer behavior supports its continued growth: pet owners are increasingly migrating their purchases from veterinary offices to the channels they serve. In addition, pet owners are transferring retail purchases of non-veterinary grade products, the only available product in their retail channels, to advanced veterinary grade products sold.

Company Financials

EPS

PETQ has released its 2024 Q2 earnings. EPS was reported at 0.7, versus the expected 0.5, beating expectations. The chart below visualizes how PETQ has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

PETQ has released its 2024 Q2 earnings report, with revenue of 328.94M, reflecting a YoY change of 4.58%, and net profit of 15.47M, showing a YoY change of 61.90%. The Sankey diagram below clearly presents PETQ's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

No Data

You can ask Aime

No Data